Enclomiphene Citrate 10 mg/tab – US Stock

Enclomiphene Citrate 10 mg/tab from Hilma Biocare is an oral tablet formulation containing enclomiphene citrate, the trans-isomer of clomiphene citrate. Each uncoated tablet contains 10 mg of active ingredient, with 50 tablets supplied per bottle.

Product Overview

Enclomiphene is classified as a selective estrogen receptor modulator (SERM). The supplied product information describes it as the trans-isomer of clomiphene citrate and states that it acts through the hypothalamic-pituitary-gonadal axis, influencing the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH).

The source material identifies the product under the anabolic steroid group with an oral/tablet presentation. It also specifies that the product does not retain water and does not aromatize.

Active Ingredient

The active ingredient is Enclomiphene Citrate. The supplied description identifies enclomiphene as the trans-isomer of clomiphene citrate.

Dosage Form and Strength

Enclomiphene Citrate is supplied as an oral, uncoated tablet containing 10 mg of active ingredient per tablet.

Product Characteristics

According to the supplied product information, Enclomiphene Citrate has the following characteristics:

• Oral tablet formulation
• 10 mg Enclomiphene Citrate per tablet
• 50 uncoated tablets per bottle
• Selective estrogen receptor modulator (SERM)
• Trans-isomer of clomiphene citrate
• No water retention listed in the supplied specifications
• No aromatization listed in the supplied specifications

Product Specifications

Product Characteristics

Enclomiphene Citrate is the trans-isomer of clomiphene citrate. The supplied information describes its activity in relation to the hypothalamic-pituitary-gonadal axis and the secretion of LH and FSH.

The source material also distinguishes enclomiphene from standard clomiphene citrate by describing it as containing only the trans-isomer rather than a mixture of isomers. Claims concerning hormonal effects, fertility, estrogenic activity, or individual outcomes should not be interpreted as guaranteed results.

Reported Side Effects

The supplied information lists several possible adverse reactions, including nausea or vomiting, headache, dizziness, visual disturbances, mood changes, breast tenderness, hormonal fluctuations, and other reactions. It also identifies potentially serious symptoms such as breathing difficulty and swelling involving the face, lips, tongue, or throat.

Women-specific effects listed in the source include menstrual irregularities, pelvic discomfort, ovarian cysts, and vaginal bleeding.

Because Enclomiphene Citrate affects hormonal signaling, individuals should consult an appropriately qualified healthcare professional regarding potential risks, contraindications, and medication interactions.

Storage & Handling

The supplied product information recommends storing Enclomiphene Citrate in a cool, dry place between 15–25°C and protecting the product from direct sunlight.

Important Information

This product contains a hormonally active compound and is intended to be considered using appropriate professional medical guidance. The information on this page is provided for product identification and factual specification purposes and does not constitute personalized medical advice.

No dosing recommendations, treatment protocols, stacking instructions, or instructions for self-administration are provided. Potential interactions with hormone therapies, blood thinners, prescription medicines, supplements, and other compounds should be discussed with a healthcare professional before use.

About Hilma Biocare USA

Enclomiphene Citrate 10 mg/tab is part of the Hilma Biocare product range. The product is supplied as 50 uncoated tablets per bottle, with each tablet containing 10 mg of Enclomiphene Citrate, and is listed as US Stock.